Sage Journals: Discover world-class research

Abstract

Understanding the public health impact of women’s health research is crucial for improving health outcomes and guiding future research priorities. Bibliometric analysis offers a unique suite of tools to identify opportunities to increase impact and measure the dissemination of women’s health research. Using 2018–2021 mortality data from the National Vital Statistics System, we utilized age-adjusted death rates to identify conditions with the highest relative mortality risk for females versus males. Our analysis showed that breast cancer, Alzheimer’s disease, infections of the kidney, and acute rheumatic fever and chronic rheumatic heart diseases were associated with the highest relative mortality risk for females. Using a systematic keyword search strategy, we identified 219 Centers for Disease Control and Prevention (CDC)-authored publications published between 2018 and 2023 featuring these conditions in a database of CDC-authored publications. For relevant publications on each condition, we evaluated five bibliometric indicators measuring media attention, academic citations, and policy citations. Overall, CDC’s publications on these conditions did not demonstrate a gap in media attention, academic citations, and policy citations compared with other agency publications, underscoring the agency’s effectiveness in disseminating its research on these topics. Assessing bibliometric indicators for published research on conditions with disproportionate relative mortality risk for females can reveal potential gaps in research coverage, highlight research successes, and inform strategic decisions for disseminating women’s health research.

Keywords

Centers for Disease Control and Prevention National Vital Statistics System National Center for Health Statistics mortality bibliometrics women’s health research

Get full access to this article

View all access options for this article.

References

Centers for Disease Control and Prevention. Four in 5 pregnancy-related deaths in the U.S. are preventable. CDC Newsroom Releases 2022 September 19, 2022; Available from: https://www.cdc.gov/media/releases/2022/p0919-pregnancy-related-deaths.html

Centers for Disease Control and Prevention. State Strategies for Preventing Pregnancy-Related Deaths: A Guide for Moving Maternal Mortality Review Committee Data to Action. 2022. Available from: https://www.cdc.gov/maternal-mortality/media/pdfs/State-Strategies-508.pdf

Centers for Disease Control and Prevention Washington. Are CDC’s Priorities Restoring Public Trust and Improving the Health of the American People? CDC Congressional Testimony. 2024. Available from: https://www.cdc.gov/washington/testimony/2024/t20240723.htm

Parker

, Zhu

B-P

, Li

, et al. Domains of excellence: A CDC framework for developing high-quality, impact-driven public health science publications. J Public Health Manag Pract, 2024; 30(1):72–78.

Bunnell

, Ryan

, Kent

, CDC Office of Science and CDC Excellence in Science Committee. Toward a new strategic public health science for policy, practice, impact, and health equity. Am J Public Health, 2021; 111(8):1489–1496.

Belter

. Bibliometric indicators: Opportunities and limits. J Med Libr Assoc, 2015; 103(4):219–221.

Agarwal

, Durairajanayagam

, Tatagari

, et al. Bibliometrics: Tracking research impact by selecting the appropriate metrics. Asian J Androl, 2016; 18(2):296–309.

Ninkov

, Frank

, and Maggio

. Bibliometrics: Methods for studying academic publishing. Perspect Med Educ, 2022; 11(3):173–176.

Donthu

, Kumar

, Mukherjee

, et al. How to conduct a bibliometric analysis: An overview and guidelines. J Bus Res, 2021; 133:285–296.

10.

Ortega

, et al. From research to impact: Assessing a decade of CDC’s public health science by topic area, 2014–2023. medRxiv, 2025 p:2025.

11.

Centers for Disease Control and Prevention. N.C.f.H.S., National Vital Statistics System, Mortality 2018-2022 on CDC WONDER Online Database. 2024.

12.

U.S. DEPARTMENT of HEALTH AND HUMAN SERVICES, Centers for Disease Control and Prevention, and National Center for Health Statistics. Instruction Manual-Part 9: ICD-10 Cause-of-Death Lists for Tabulating Mortality Statistics (Updated October 2020 to include WHO updates to ICD-10 for data year 2020). 2020. Available from: https://www.cdc.gov/nchs/data/dvs/Part9InstructionManual2020-508.pdf

13.

Stephen

. Thacker CDC Library. CDC Science Clips 2024. 2025. Available from: https://phgkb.cdc.gov/PHGKB/cdcSCStartPage.action

14.

Elmore

. The Altmetric Attention Score: What does it mean and why should I care? Toxicol Pathol, 2018; 46(3):252–255.

15.

Altmetric. The donut and Altmetric Attention Score. Available from: https://www.altmetric.com/about-us/our-data/donut-and-altmetric-attention-score/?_gl=1*etexyp*_up*MQ.*_ga*MTc3MTU0MDQ1Mi4xNzI3ODc4ODI0*_ga_M5HG97K2C0*MTcyNzg3ODgyNC4xLjAuMTcyNzg3ODgyNC4wLjAuMA

16.

Altmetric. Altmetric Explorer. 2024. explorer.altmetric.com.

17.

Abramo

, Cicero

, and D’Angelo

. Assessing the varying level of impact measurement accuracy as a function of the citation window length. J Informetr, 2011; 5(4):659–667.

18.

Wang

. Citation time window choice for research impact evaluation. Scientometrics, 2013; 94(3):851–872.

19.

Digital Science & Research Solutions Inc. Dimensions: A Digital Science Solution. 2024. Available from: https://www.dimensions.ai/

20.

BMJ Publishing Group. BMJ Impact Analytics. BMJ Publishing Group; 2024.

21.

U.S. Cancer Statistics Working Group. Cancer Statistics Data Visualizations Tool. 2024; Available from: https://www.cdc.gov/cancer/dataviz

22.

2022 Alzheimer’s disease facts and figures. Alzheimers Dement, 2022; 18(4):700–789.

23.

Pai

. Why women may be more prone to Alzheimer’s disease. Aging Brain, 2024; 6:100121.

24.

World Health Organization. Rheumatic fever and rheumatic heart disease. 2018. Available from: https://apps.who.int/gb/ebwha/pdf_files/WHA71/A71_25-en.pdf

25.

Remenyi

, and Carapetis

. Acute Rheumatic Fever and Chronic Rheumatic Disease, in Pediatric and Congenital Cardiology, Cardiac Surgery and Intensive Care. ( Cruz

E.M. Da

, Ivy

, and Jaggers

., eds). 2014, Springer London: London. pp. 2329–2350.

26.

Belyayeva

, Leslie

, and Jeong

27.

Sujith

, Solomon

, and Rayappan

JBB

. Comprehensive insights into UTIs: From pathophysiology to precision diagnosis and management. Front Cell Infect Microbiol, 2024; 14:1402941.

28.

Dimmock

, Mirin

, and Jason

. Estimating the disease burden of ME/CFS in the United States and its relation to research funding. J Med Ther, 2016; 1(1):1–7.

29.

Mirin

. Gender disparity in the funding of diseases by the U.S. National Institutes of Health. J Womens Health (Larchmt), 2021; 30(7):956–963.

30.

Mirin

, Dimmock

, and Jason

. Research update: The relation between ME/CFS disease burden and research funding in the USA. Work, 2020; 66(2):277–282.

31.

Spencer

, Rice

, Ye

, et al. Disparities in the allocation of research funding to gynecologic cancers by funding to lethality scores. Gynecol Oncol, 2019; 152(1):106–111.

32.

Casadevall

, Fang Ferric

. Causes for the persistence of impact factor mania. mBio, 2014; 5(2):e00064–14; doi: 10.1128/mbio.00064-14

33.

Konkiel

. Altmetrics: diversifying the understanding of influential scholarship. Palgrave Communications, 2016. 2(1): p. 16057.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.23 MB

0.07 MB

0.03 MB

0.05 MB